Buscar
Mostrando ítems 1-10 de 1093
Commentary: A humanized clinically calibrated quantitative systems pharmacology model for hypokinetic motor symptoms in Parkinson's disease
(Frontiers Research Foundation, 2016)
Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
(American Chemical Society, 2017)
© 2017 American Chemical Society. In 1967, L-dopa was introduced as part of the pharmacological therapy of Parkinson's disease (PD) and, in spite of extensive research, no additional effective drugs have been discovered ...
Neuronal dysfunction in down syndrome: contribution of neuronal models in cell culture
(CAMBRIDGE UNIVERSITY PRESS, 2006)